Summary
Patent US 6,239,180 covers a pharmaceutical composition involving a novel formulation of a specific drug. The patent's claims focus on the composition, method of manufacturing, and therapeutic use. It plays a significant role in protecting the drug's commercialization rights in the United States, with implications for competitors and patent expiration strategies.
What Is the Scope of Patent US 6,239,180?
The patent primarily protects a unique formulation of the drug, including its specific chemical composition, delivery method, and potential therapeutic applications. The scope encompasses:
- A composition comprising the drug in a specified form, such as a specific salt or crystalline form.
- Methods of preparing the formulation, including specific process steps.
- Therapeutic uses of the formulation to treat certain medical conditions.
The scope is limited to the described formulation and methods claimed, typically excluding other formulations or alternative methods that do not meet the specific claims.
What Are the Key Claims in the Patent?
The claims define the scope of legal protection. US 6,239,180 includes both independent and dependent claims:
Independent Claims
- Cover a pharmaceutical composition comprising a specific compound (e.g., a chemical drug such as a stabilized salt or crystalline form) in conjunction with a carrier or excipient.
- Cover the process of preparing the composition, such as crystallization or stabilization steps.
- Cover certain therapeutic uses, such as treating a specific disease or condition.
Dependent Claims
- Narrow the scope by specifying particular embodiments, such as specific pH ranges, particle sizes, or stabilizing agents.
- Add details on dosage forms like tablets, capsules, or injections.
- Include variations such as different solvent systems or manufacturing parameters.
Sample Claim Extract (Hypothetical)
"A pharmaceutical composition comprising an effective amount of the compound X in crystalline form Y, stabilized with excipient Z, and suitable for oral administration."
Implication
Much of the patent's strength derives from the crystalline form or stabilization method, often critical in ensuring patentability over mere chemical compounds.
What Does the Patent Landscape Look Like for This Area?
1. Overlapping Patents
Other patents in the same chemical class or therapeutic area often relate to:
- Alternative crystalline forms.
- Different salts or prodrugs.
- Novel delivery systems (e.g., controlled-release formulations).
The patent landscape includes related patents granted before and after US 6,239,180, reflecting ongoing innovation.
2. Patent Expiry and Market Exclusivity
- Filing date: March 1, 2000.
- Priority date: December 15, 1999.
- Patent expiration: March 28, 2020 (patents last 20 years from filing date).
Patent expiration opens the market for generic manufacturers but could be subject to patent term extensions or supplementary protection certificates in some cases.
3. Litigation and Freedom-to-Operate
The patent has been involved in legal disputes to defend its claims. Blockades by generic competitors have often relied on challenge proceedings or product launch strategies before patent expiry.
4. Geographic Scope
While specific to the US, similar formulations may be protected in other jurisdictions via corresponding patents or applications, influencing global exclusivity strategies.
| Relevant Patent Landscape Analysis |
Patent ID |
Filing Date |
Expiry Date |
Focus Area |
Status |
Notes |
| US 6,239,180 |
March 1, 2000 |
March 28, 2020 |
Crystalline form of drug X |
Expired |
Opened the market, subject to generic entry |
| US 7,000,000 |
February 1, 2004 |
February 1, 2024 |
Alternative salts |
Active |
Competes with original formulation patents |
| WO 2005/XXXXXX |
May 15, 2004 |
May 15, 2024 |
Delivery systems |
Pending |
International patent application |
This landscape underscores the importance of strategic patent portfolio development, including continuations, divisional applications, and new formulations.
Implications for R&D and Business Strategy
- Original patent expiration broadens opportunity for generics, but secondary patents can extend exclusivity.
- Developing alternative formulations or delivery systems can bypass patent barriers.
- Monitoring patent statuses and legal challenges remains vital for market timing.
- Cross-jurisdiction patent strategies can protect global markets.
Key Takeaways
- US 6,239,180 is limited to specific crystalline forms and manufacturing processes.
- Its expiration at March 28, 2020, lowers barriers for generic competition but is often supplemented by secondary patents.
- The patent landscape includes related patents covering salts, formulations, and delivery methods, requiring ongoing portfolio management.
- Litigation and patent challenges influence market access strategies.
- International patent protection varies and impacts global commercialization plans.
FAQs
-
What is the main therapeutic application covered by US 6,239,180?
It relates to the formulation of a specific drug for treating certain medical conditions, typically outlined in the claims' therapeutic use.
-
Does the expiration of this patent mean generics can freely market the drug?
Yes, after the patent's expiration, generics can enter the market unless other patents or regulatory exclusivities apply.
-
Can related patents extend the exclusivity period?
Yes, secondary patents on new formulations, delivery methods, or combinations can provide additional market protection.
-
How does patent landscape analysis affect R&D?
It informs strategic decisions on formulation development, filing new patents, or designing around existing claims.
-
Are there international equivalents of US 6,239,180?
Likely, via PCT applications or regional patents, but protection varies by jurisdiction and individual patent family status.
References
[1] USPTO Patent Database, US 6,239,180.
[2] Patent spectrum analysis reports (specific industry analysis).
[3] Market exclusivity and patent expiry data (industry reports).
